Literature DB >> 11103941

Chimeric VEGFRs are activated by a small-molecule dimerizer and mediate downstream signalling cascades in endothelial cells.

E L Knight1, A J Warner, A Maxwell, S A Prigent.   

Abstract

Despite much interest in vascular endothelial growth factor (VEGF) and its receptors (VEGFRs -1 and -2), VEGF-induced signalling cascades remain incompletely defined. Attempts to assign individual responses to a particular receptor have used either transfected cell lines, receptor-specific growth factors or antisense oligonucleotides. Such studies have attributed the majority of VEGF-induced responses to activation of VEGFR-2. As a consequence of poor growth factor-induced VEGFR-1 autophosphorylation however, observations from these studies may instead reflect the relative activation of the two receptors. We have generated novel chimeric VEGF receptors in which the dimerization domain of the B subunit of DNA gyrase is fused to the cytoplasmic domain of VEGFRs -1 and -2. When expressed in porcine aortic endothelial cells, both chimeric VEGFR-1 and -2 autophosphorylate in response to addition of the small-molecule dimerizing agent, coumermycin. Once activated, both receptors induce downstream signalling cascades, exemplified here by the activation of MAPK, PLCgamma and PKB/Akt. Furthermore, we demonstrate that the Y1175 residue of VEGFR-2 is essential for the activation of PLCgamma mediated by this chimeric receptor. In contrast to previous reports which show a limited ability of VEGFR-1 to mediate signalling cascades, we show that once sufficiently activated, VEGFR-1 signals in a similar manner to VEGFR-2 in endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11103941     DOI: 10.1038/sj.onc.1203915

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  5 in total

1.  Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide.

Authors:  B Bussolati; C Dunk; M Grohman; C D Kontos; J Mason; A Ahmed
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

Review 2.  Design and Applications of Bifunctional Small Molecules: Why Two Heads Are Better Than One.

Authors:  Timothy W Corson; Nicholas Aberle; Craig M Crews
Journal:  ACS Chem Biol       Date:  2008-11-21       Impact factor: 5.100

3.  Alternative splicing controls the mechanisms of FAK autophosphorylation.

Authors:  Madeleine Toutant; Alicia Costa; Jeanne-Marie Studler; Gress Kadaré; Michèle Carnaud; Jean-Antoine Girault
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

4.  Pharmacologically controlled protein switch for ON-OFF regulation of growth factor activity.

Authors:  Maria Karlsson; Balder Rebmann; Philipp S Lienemann; Natallia Sprossmann; Martin Ehrbar; Gerald Radziwill; Wilfried Weber
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

Review 5.  The Emerging Regulation of VEGFR-2 in Triple-Negative Breast Cancer.

Authors:  Xiaoxia Zhu; Wen Zhou
Journal:  Front Endocrinol (Lausanne)       Date:  2015-10-09       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.